✦ LIBER ✦

Phase II study of biweekly irinotecan and mitomycin C combination therapy in patients with fluoropyrimidine-resistant advanced colorectal cancer

✍ Scribed by Yasuhide Yamada; Kuniaki Shirao; Ichinosuke Hyodo; Yasuaki Arai; Tadamichi Denda; Tomonori Ambo; Atsushi Ohtsu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of biweekly mitomycin C

✍ Tetsuya Hamaguchi; Kuniaki Shirao; Atsushi Ohtsu; Ichinosuke Hyodo; Yasuaki Arai 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 341 KB

A phase II study of combination therapy

✍ Manabu Shiozawa; Makoto Akaike; Nobuhiro Sugano; Kazuhito Tsuchida; Naoto Yamamo 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 347 KB

A phase I study of combination therapy w

✍ Manabu Shiozawa; Nobuhiro Sugano; Kazuhito Tsuchida; Soichiro Morinaga; Makoto A 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 296 KB

Phase II trial of irinotecan in combinat

✍ Maria L. Delioukina; Diane Prager; Mandy Parson; J. Randolph Hecht; Peter Rosen; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 2 views

Phase II study of FOLFIRI regimen in pat

✍ Han Ying Bao; Wei Jia Fang; Xiao Chen Zhang; Gen Ming Shi; Sui Huang; Lan Fang Y 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 269 KB

Mitomycin-C and capecitabine as third-li

✍ Do Hyoung Lim; Young Suk Park; Byeong-Bae Park; Sang Hoon Ji; Jeeyun Lee; Keon W 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 200 KB